Dr. Reddy’s Laboratories Limited was founded in 1984 and provides a complete range of pharmaceutical services. They manufacture medicines and drugs to supply affordable and innovative medicines. The company initially began as a supplier to Indian drug manufacturers, but soon started exporting their products to the world. Dr. Reddy is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates.
Generic Formulations, including tablets, capsules, injectables, and topical creams, is the largest part of our business portfolio, making products across the major therapeutic areas of gastrointestinal ailments, cardiovascular disease, pain management, oncology, anti-infective, pediatrics and dermatology.
The companies API Business caters to leading innovator and generic companies across the US, Europe, Latin America, Japan, Korea and other emerging markets. With deep technical strengths in the development of complex APIs such as steroids, peptides, complex long chain synthesis and oncology we consistently deliver high-quality APIs.
The company constantly strives to bring the most advanced medicines within the reach of millions around the world. The Biologics division works on high quality global biosimilars for the last fifteen years.